Quality of life is an important indication for second-line treatment in children with immune thrombocytopenia.

Shimano KA, Neunert C, Bussel JB, Klaassen RJ, Bhat R, Pastore YD, Lambert MP, Bennett CM, Despotovic JM, Forbes P, Grace RF